Evidence map›Paper›PMID 33531085›Full record

ArticleInfectious diseases of poverty2021

COVID-19 case fatality risk by age and gender in a high testing setting in Latin America: Chile, March-August 2020.

Eduardo A Undurraga, Gerardo Chowell, Kenji Mizumoto

Open access · goldAbstract read
In one paragraph

Article in Infectious diseases of poverty, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Fucoidan sulfate fromJournal of Zhejiang University. Science. B · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. RNA sequence analysis of nasopharyngeal swabs from asymptomatic and mildly symptomatic patients with COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Eduardo A UndurragaEscuela de Gobierno, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Macul, CP 7820436, Santiago, Región Metropolitana, Chile. eundurra@uc.cl.ORCID http://orcid.org/0000-0002-4425-1253
Gerardo ChowellDepartment of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA.
Kenji MizumotoGraduate School of Advanced Integrated Studies in Human Survivability, Kyoto University Yoshida-Nakaadachi-Cho, Sakyo-ku, Kyoto, Japan.
Georgia State University · USKyoto University · JPPontificia Universidad Católica de Chile · CL

Funding

ANID Millennium Science Initiative NCN17_081Biotechnology and Biological Sciences Research Council BB/M008894/1Japan Society for the Promotion of Science 20H03940Ministry of Education, Culture, Sport, Science & Technology of Japan Leading Initiative for Excellent Young ResearchersNational Science Foundation 1414374
6 · The paper itself

Abstract

backgroundEarly severity estimates of coronavirus disease 2019 (COVID-19) are critically needed to assess the potential impact of the ongoing pandemic in different demographic groups. Here we estimate the real-time delay-adjusted case fatality rate across nine age groups by gender in Chile, the country with the highest testing rate for COVID-19 in Latin America.

methodsWe used a publicly available real-time daily series of age-stratified COVID-19 cases and deaths reported by the Ministry of Health in Chile from the beginning of the epidemic in March through August 31, 2020. We used a robust likelihood function and a delay distribution to estimate real-time delay-adjusted case-fatality risk and estimate model parameters using a Monte Carlo Markov Chain in a Bayesian framework.

resultsAs of August 31, 2020, our estimates of the time-delay adjusted case fatality rate (CFR) for men and women are 4.16% [95% Credible Interval (CrI): 4.09-4.24%] and 3.26% (95% CrI: 3.19-3.34%), respectively, while the overall estimate is 3.72% (95% CrI: 3.67-3.78%). Seniors aged 80 years and over have an adjusted CFR of 56.82% (95% CrI: 55.25-58.34%) for men and 41.10% (95% CrI: 40.02-42.26%) for women. Results showed a peak in estimated CFR during the June peak of the epidemic. The peak possibly reflects insufficient laboratory capacity, as illustrated by high test positivity rates (33% positive 7-day average nationally in June), which may have resulted in lower reporting rates.

conclusionsSeverity estimates from COVID-19 in Chile suggest that male seniors, especially among those aged ≥ 70 years, are being disproportionately affected by the pandemic, a finding consistent with other regions. The ongoing pandemic is imposing a high death toll in South America, and Chile has one of the highest reported mortality rates globally thus far. These real-time estimates may help inform public health officials' decisions in the region and underscore the need to implement more effective measures to ameliorate fatality.

Indexed as

SARS-CoV-2AdolescentAdultAgedAged, 80 and overAge DistributionChildChild, PreschoolChileCOVID-19FemaleHumansInfantInfant, NewbornMaleMiddle AgedChileCOVID-19Death risk by age groupLatin AmericaTime-delay adjusted case fatality rate

Identifiers

PMID33531085
PMCPMC7854021
OpenAlexW3128430125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.